E
Velocity Clinical Research’s site in Skierniewice, Poland, was established in 2000 as ClinMedica Research and acquired by Velocity in 2023. As the largest clinical research facility in the region, the site specializes in conducting Phase II-IV clinical trials across a wide range of therapeutic areas, including cardiology, dermatology, pulmonology, endocrinology, metabolic diseases, gastroenterology, and population-based vaccine studies.
Recognized for its strong reputation and exceptional patient care, Velocity Skierniewice is highly regarded by sponsors and contract research organizations (CROs). The site maintains close ties with Ogrodowa Medical Center and local communities, allowing for fast and accurate patient recruitment, even for diverse populations. With a commitment to advancing medicine through research, the Skierniewice team combines decades of experience with high-quality, compassionate patient care to support a broad array of clinical studies.